Altoida

Altoida, Inc. is a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnosis through AI and augmented reality (AR). Altoida's technology platform uses artificial intelligence (AI) to analyze cognitive and functional test results and assists in diagnosing neurological conditions such as mild cognitive impairment (MCI) and Alzheimer’s disease. The proprietary 10-minute digital test activity set (completed on a smartphone or tablet) utilizes augmented reality (AR) to simulate real-world daily living activities, enabling the capture of cognitive and functional changes earlier and more accurately than existing methods. The platform has received FDA Breakthrough Device designation.